Drug: NEVIRAPINE. Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 35 Number of Pages: 2
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
126282221 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
126282491 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
126282571 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
126282591 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
126282621 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
126282771 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
126283311 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
126283671 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
126396041 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160810 | CA | |
126894951 | NEVIRAPINE. | Foetal exposure during pregnancy | ROCHE | 0.00 | 0 | 20160826 | US | |
127362581 | NEVIRAPINE. | Foetal exposure during pregnancy | AUROBINDO | 0.00 | 0 | 20160913 | GB | |
127451332 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US | |
127451412 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US | |
127459241 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US | |
127460651 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US |
Total Records: 35 Number of Pages: 2